177 related articles for article (PubMed ID: 38101828)
21. Pancreatic Carcinosarcoma Clinical Outcome Analysis of the National Cancer Institute Database.
Alhatem A; Quinn PL; Xia W; Chokshi RJ
J Surg Res; 2021 Mar; 259():62-70. PubMed ID: 33279845
[TBL] [Abstract][Full Text] [Related]
22. The prognostic effect of metastasis patterns on overall survival in patients with distant metastatic bladder cancer: a SEER population-based analysis.
Shou J; Zhang Q; Zhang D
World J Urol; 2021 Nov; 39(11):4151-4158. PubMed ID: 34028594
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for metastasis and poor prognosis of Ewing sarcoma: a population based study.
Shi J; Yang J; Ma X; Wang X
J Orthop Surg Res; 2020 Mar; 15(1):88. PubMed ID: 32131863
[TBL] [Abstract][Full Text] [Related]
24. Outcome of adjuvant radiotherapy after total hysterectomy in patients with uterine leiomyosarcoma or carcinosarcoma: a SEER-based study.
Li Y; Ren H; Wang J
BMC Cancer; 2019 Jul; 19(1):697. PubMed ID: 31307426
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Value of Site-Specific Metastases and Therapeutic Roles of Surgery and Chemotherapy for Patients With Metastatic Renal Pelvis Cancer: A SEER Based Study.
Chen WK; Wu ZG; Xiao YB; Wang QQ; Yu DD; Cai J; Zhou CF
Technol Cancer Res Treat; 2021; 20():15330338211004914. PubMed ID: 33929915
[TBL] [Abstract][Full Text] [Related]
26. Improved survival in patients with isolated liver metastasis at initial diagnosis with surgery at primary and metastatic sites: A population-based study in patients with breast cancer.
Chai Y; Chen Y; Liu J; He M; Jiang M; Xu B; Li Q
Thorac Cancer; 2023 Sep; 14(27):2793-2803. PubMed ID: 37558505
[TBL] [Abstract][Full Text] [Related]
27. Leiomyosarcoma of the urinary bladder: A SEER database study and comparison to leiomyosarcomas of the uterus and extremities/trunk.
Coiner BL; Cates J; Kamanda S; Giannico GA; Gordetsky JB
Ann Diagn Pathol; 2021 Aug; 53():151743. PubMed ID: 33964611
[TBL] [Abstract][Full Text] [Related]
28. Clinical characteristics and prognosis of pulmonary large cell carcinoma: A population-based retrospective study using SEER data.
Xiaochuan L; Jiangyong Y; Ping Z; Xiaonan W; Lin L
Thorac Cancer; 2020 Jun; 11(6):1522-1532. PubMed ID: 32301286
[TBL] [Abstract][Full Text] [Related]
29. Incidence and survival rates of primary uterine carcinosarcoma in Korea: a National Cancer Registry study.
Kim SI; Kim JH; Lee C; Ha J; Jung KW; Lim MC
J Gynecol Oncol; 2023 Jan; 34(1):e9. PubMed ID: 36366811
[TBL] [Abstract][Full Text] [Related]
30. Uterine Sarcoma: Clinical Presentation, Treatment and Survival Outcomes in Thailand.
Potikul C; Tangjitgamol S; Khunnarong J; Srijaipracharoen S; Thavaramara T; Pataradool K
Asian Pac J Cancer Prev; 2016; 17(4):1759-67. PubMed ID: 27221849
[TBL] [Abstract][Full Text] [Related]
31. Patterns of care, predictors, and outcomes of chemotherapy in elderly women with early-stage uterine carcinosarcoma: a population-based analysis.
Garg G; Yee C; Schwartz K; Mutch DG; Morris RT; Powell MA
Gynecol Oncol; 2014 May; 133(2):242-9. PubMed ID: 24561247
[TBL] [Abstract][Full Text] [Related]
32. A novel nomogram for predicting cancer-specific survival in women with uterine sarcoma: a large population-based study.
Li YJ; Lyu J; Li C; He HR; Wang JF; Wang YL; Fang J; Ji J
BMC Womens Health; 2022 May; 22(1):175. PubMed ID: 35568940
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of chemotherapy and radiotherapy in the adjuvant management of uterine carcinosarcoma: a population-based analysis.
Ding L; Bi Z; Wu J; Zhu J; Yu Y; Yao HR; Liu YM
Arch Gynecol Obstet; 2023 Mar; 307(3):891-901. PubMed ID: 35708782
[TBL] [Abstract][Full Text] [Related]
34. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
Milano AF
J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
[No Abstract] [Full Text] [Related]
35. Stage III uterine carcinosarcoma: 2009 International Federation of Gynecology and Obstetrics Staging System and Prognostic Determinants.
Garg G; Kruger M; Christensen C; Deppe G; Toy EP
Int J Gynecol Cancer; 2011 Dec; 21(9):1606-12. PubMed ID: 21720252
[TBL] [Abstract][Full Text] [Related]
36. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
37. Carcinosarcoma is an aggressive subtype of bladder cancer: A population-based study.
Liu L; Zhu J; Tian Y
Cancer Med; 2022 Jun; 11(11):2216-2223. PubMed ID: 35179304
[TBL] [Abstract][Full Text] [Related]
38. Conditional survival in patients with gallbladder cancer.
Kim YJ; Kim K
Chin J Cancer; 2017 Oct; 36(1):85. PubMed ID: 29084608
[TBL] [Abstract][Full Text] [Related]
39. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder.
Wright JL; Black PC; Brown GA; Porter MP; Kamat AM; Dinney CP; Lin DW
J Urol; 2007 Dec; 178(6):2302-6; discussion 2307. PubMed ID: 17936803
[TBL] [Abstract][Full Text] [Related]
40. Ovarian and uterine carcinosarcomas: a comparative analysis of prognostic variables and survival outcomes.
Garg G; Shah JP; Kumar S; Bryant CS; Munkarah A; Morris RT
Int J Gynecol Cancer; 2010 Jul; 20(5):888-94. PubMed ID: 20606539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]